At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 24 approved innovative cancer medicines and biosimilars across more than 30 indications. Going forward, we are focused on delivering a next wave of breakthroughs in breast cancer, genitourinary cancer, hematology and precision medicine.
Booth Number
1624
Short Description
Pfizer Oncology is committed to advancing medicines wherever we believe we can make a difference for people living with cancer. We have an industry-leading portfolio of 24 approved cancer medicines and biosimilars across 30+ indications—and are focused on delivering breakthroughs in breast cancer, genitourinary cancer, hematology and precision medicine.